14-day Premium Trial Subscription Try For FreeTry Free

Why Is ViewRay (VRAY) Stock Down 69% Today?

10:41am, Monday, 17'th Jul 2023
ViewRay (NASDAQ: VRAY ) stock is falling hard on Monday after the MRI company announced its voluntary Chapter 11 bankruptcy filing! According to the company's bankruptcy filing, ViewRay intends to pur
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
ViewRay (VRAY) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.14 per share a year ago.
Magnetic resonance imaging-guided radiation therapy system provider ViewRay, Inc. has shocked investors with a severe revenue and cash flow warning. Expected 2023 revenue growth range slashed from a
DENVER , April 12, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) will hold a conference call to discuss results on Thursday, April 13, 2023, at 8:00 AM ET. The dial-in number 
Penny stocks with unusual options activity. The post Penny Stocks To Buy Now?
ViewRay, Inc. (NASDAQ:VRAY ) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ET Company Participants Matt Harrison - Director of IR Scott Drake - President and CEO Bill Burke - CFO Conferen
ViewRay (VRAY) delivered earnings and revenue surprises of 6.25% and 0.71%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ViewRay has continued growth in order momentum. Its stock price has moved sideways into the new year, adding another attractive entry point.
DENVER , Jan. 31, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today details relating to the release of fourth quarter 2022 financial results. ViewRay will hold a conference call to dis
Revised FY22 revenue guidance with management more confident on the lower end of range. Backlog continues to grow, ending 26% higher to $350mm for the third quarter.
DENVER , Nov. 10, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Stifel 2022 Healthcare Conference. Scott Drake, President and Chief Executive O
ViewRay, Inc. (NASDAQ:VRAY ) Q3 2022 Results Conference Call November 1, 2022 5:00 PM ET Company Participants Matt Harrison - Director, IR Scott Drake - President & CEO Zach Stassen - CFO Dr. Paul Str
ViewRay (VRAY) delivered earnings and revenue surprises of 0% and 4.02%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
DENVER, Oct. 14, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today details relating to the release of third quarter 2022 financial results. ViewRay will hold a conference call to discu
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE